• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Increasing the efficacy of treating patients with extensive ovarian cancer by using laferon].

作者信息

Zhyl'chuk V Ie

出版信息

Lik Sprava. 1998 May(3):117-9.

PMID:9695587
Abstract

Patients with stage III-IV cancer of the ovary have been shown to derive a greater benefit from conventional complex treatments involving adjuvant laferon therapy. Intraperitoneal and systemic administration of laferon lessens intoxication caused by specific antitumoral drugs, promotes longer stabilization of the process and extends patients' length of life.

摘要

相似文献

1
[Increasing the efficacy of treating patients with extensive ovarian cancer by using laferon].
Lik Sprava. 1998 May(3):117-9.
2
[The evaluation of the efficacy of adjuvant laferon therapy in the combined treatment of patients with ovarian cancer based on the monitoring of the tumor marker Ca-125 in the blood serum].[基于血清肿瘤标志物Ca-125监测评估辅助拉弗隆疗法在卵巢癌患者联合治疗中的疗效]
Lik Sprava. 1998 Mar-Apr(2):137-9.
3
Randomized trial of adjuvant intraperitoneal alpha-interferon in stage III ovarian cancer patients who have no evidence of disease after primary surgery and chemotherapy: An intergroup study.辅助性腹腔内注射α-干扰素用于Ⅲ期卵巢癌患者的随机试验，这些患者在初次手术和化疗后无疾病证据：一项组间研究。
Gynecol Oncol. 2006 Jan;100(1):133-8. doi: 10.1016/j.ygyno.2005.07.117. Epub 2005 Sep 8.
4
[Treatment outcomes for advanced ovarian cancers with peritoneal dissemination].[伴有腹膜播散的晚期卵巢癌的治疗结果]
Gan To Kagaku Ryoho. 2011 Apr;38(4):591-7.
5
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.新辅助化疗与初始肿瘤细胞减灭术用于 IIIC 或 IV 期卵巢癌。
N Engl J Med. 2010 Sep 2;363(10):943-53. doi: 10.1056/NEJMoa0908806.
6
Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.辅助化疗和手术分期对早期卵巢癌的影响：欧洲癌症研究与治疗组织-卵巢肿瘤辅助化疗试验
J Natl Cancer Inst. 2003 Jan 15;95(2):113-25.
7
[Interperitoneal alpha-2b interferon for advanced ovarian cancer in complete remission or minimal residual disease].[腹腔内注射α-2b干扰素治疗完全缓解或微小残留病的晚期卵巢癌]
J Gynecol Obstet Biol Reprod (Paris). 1996;25(1):101-2.
8
Adjuvant therapy with intraperitoneal chromic phosphate (32P) in women with early ovarian carcinoma after comprehensive surgical staging.早期卵巢癌女性患者在全面手术分期后采用腹腔内注射磷酸铬（32P）进行辅助治疗。
Obstet Gynecol. 1992 Jun;79(6):993-7.
9
International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.国际卵巢癌协作组试验1和卵巢癌辅助化疗试验：两项针对早期卵巢癌患者辅助化疗的平行随机III期试验。
J Natl Cancer Inst. 2003 Jan 15;95(2):105-12.
10
[Super radical surgery of advanced ovarian cancers (stages III and IV)].[晚期卵巢癌（III期和IV期）的超根治性手术]
Contracept Fertil Sex. 1997 Jun;25(6):V-XI.

引用本文的文献

1
Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer.晚期（II-IV期）上皮性卵巢癌女性术后使用干扰素的情况。
Cochrane Database Syst Rev. 2013 Jun 6;2013(6):CD009620. doi: 10.1002/14651858.CD009620.pub2.